Stock listing

BME:LAB Labiana Health SA Acciones

Home listing (Madrid) of Labiana Health SA

Follow Labiana Health SA into a list and get an email when it puts out news.

Share price · BME:LAB

€4.76 EUR 0.00 (0.0%)

Close on Nov 20, 2026

Past year +5.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
€4.76 – €4.76 EURNov 20, 2026
Volume
2,575 sharesNov 20, 2026
Market cap
€40.41M EURAt the close on Nov 20, 2026 · price × 8.49M shares outstanding
52-week range
€4.24 – €8.20 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€23,140 EURMedian day 2,293 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Labiana Health SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
BME:LAB · Home€4.76 EUR0.00 (0.0%)2,575€4.76€4.76€4.76€4.76Close on Nov 20, 2026
Frankfurt:8RK€4.60 EUR0.00 (0.0%)—€4.64€4.64€4.60€4.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · BME:LAB · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€4.760.000.0%€4.76€4.76€4.762,575
€4.76-0.06-1.2%€4.80€4.80€4.761,245
€4.820.000.0%€4.84€4.90€4.801,515
€4.82+0.02+0.4%€4.88€4.88€4.702,258
€4.80-0.04-0.8%€4.84€4.88€4.706,266
€4.84-0.06-1.2%€5.00€5.00€4.841,354
€4.90-0.04-0.8%€5.00€5.00€4.904,965
€4.94-0.06-1.2%€4.94€5.00€4.9419,443
€5.00-0.05-1.0%€5.00€5.00€4.942,865
€5.050.000.0%€5.25€5.25€5.001,298
€5.05-0.05-1.0%€5.25€5.25€5.001,298
€5.100.000.0%€5.10€5.10€5.1063
€5.100.000.0%€5.10€5.25€5.10752
€5.10-0.10-1.9%€5.15€5.15€5.05924
€5.20-0.20-3.7%€5.55€5.55€5.152,472
€5.40+0.10+1.9%€5.30€5.55€5.253,222
€5.300.000.0%€5.30€5.30€5.155,332
€5.30-0.20-3.6%€5.45€5.45€5.201,066
€5.50+0.45+8.9%€5.10€5.50€5.105,497
€5.05+0.05+1.0%€5.00€5.10€4.924,300
€5.00+0.20+4.2%€4.90€5.00€4.889,804
€4.80-0.06-1.2%€4.88€4.88€4.8026,968
€4.86-0.08-1.6%€4.98€4.98€4.862,556
€4.94+0.04+0.8%€4.96€4.96€4.92658
€4.90-0.20-3.9%€5.05€5.10€4.889,383
€5.10-0.05-1.0%€5.20€5.20€4.964,750
€5.15+0.10+2.0%€5.05€5.20€5.002,875
€5.05-0.20-3.8%€5.15€5.20€5.053,720
€5.25-0.10-1.9%€5.30€5.30€5.2013,646
€5.350.000.0%€5.30€5.45€4.8452,768
€5.35-0.25-4.5%€5.55€5.55€5.3510,589
€5.60-0.10-1.8%€5.60€5.60€5.601,770
€5.70-0.05-0.9%€5.80€5.85€5.603,905
€5.75-0.15-2.5%€5.90€5.90€5.753,522
€5.900.000.0%€5.90€6.00€5.90288
€5.900.000.0%€6.05€6.05€5.90874
€5.90-0.20-3.3%€6.10€6.10€5.903,368
€6.100.000.0%€6.10€6.10€6.101,396
€6.100.000.0%€6.10€6.15€6.10358
€6.10+0.10+1.7%€6.10€6.20€6.001,917
€6.000.000.0%€6.10€6.10€6.001,581
€6.000.000.0%€6.00€6.05€6.002,962
€6.00-0.30-4.8%€6.10€6.10€6.002,437
€6.30+0.25+4.1%€5.85€6.30€5.853,135
€6.05+0.05+0.8%€6.10€6.10€5.858,287
€6.00-0.15-2.4%€6.10€6.15€5.7512,187
€6.15-0.05-0.8%€6.15€6.20€6.151,770
€6.200.000.0%€6.10€6.20€6.10275
€6.200.000.0%€6.30€6.30€6.201,004
€6.20-0.20-3.1%€6.20€6.20€6.20660
€6.400.000.0%€6.30€6.40€6.30294
€6.40+0.20+3.2%€6.10€6.45€6.102,388
€6.200.000.0%€6.20€6.20€6.203,990
€6.200.000.0%€6.45€6.45€6.208
€6.200.000.0%€6.20€6.20€6.201,730
€6.200.000.0%€6.20€6.20€6.20597
€6.200.000.0%€6.20€6.20€6.2074
€6.200.000.0%€6.25€6.45€6.201,202
€6.200.000.0%€6.20€6.20€6.202,293
€6.20-0.05-0.8%€6.25€6.35€6.202,293
€6.25-0.05-0.8%€6.30€6.30€6.253,849
€6.30-0.20-3.1%€6.40€6.50€6.302,645
€6.50+0.15+2.4%€6.50€6.50€6.502,000
€6.35+0.05+0.8%€6.30€6.50€6.301,723
€6.300.000.0%€6.30€6.30€6.30493
€6.300.000.0%€6.55€6.55€6.30493
Ticker
BME:LAB
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Madrid
Currency
EUR

What changed lately

Labiana Health SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
Decks
3 decks · latest October 2026

Where Labiana Health SA is listed

ListingExchangeCountryCurrency
BME:LAB · Home listing · This pageMadridSpainEUR
Lang & Schwarz:A3DQE7Lang & SchwarzGermanyEUR
LS Exchange:A3DQE7LS ExchangeGermanyEUR
Frankfurt:8RKFrankfurtGermanyEUR
Stuttgart:8RKStuttgartGermanyEUR

Valuation

P/E 15.7× against a median of 38.1×: the lowest of 2 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026

Enterprise value
€64.30M EUR
P/E
15.7×
EV/sales
0.9×
EV/EBITDA
5.8×
Price/book
8.0×
Gross margin
61.2%
Operating margin
9.7%
Net margin
3.4%
Debt to equity
5.9×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Labiana Health SA · BME:LABUS$44.35MUS$70.57M15.7×0.9×5.8×8.0×3.4%5.9×n/a
Celemics, Inc. · KRX:331920US$49.19MUS$32.45Mn/a8.4×n/a2.2×−260.9%0.5×n/a
Lumos Diagnostics Holdings Ltd. · ASX:LDXUS$47.13MUS$37.64Mn/a2.8×n/a2.1×−37.5%0.3×n/a
Renalytix PLC · LSE:RENXUS$45.66MUS$45.26Mn/a15.1×n/an/a−680.0%n/an/a
Access Bio, Inc. · KRX:950130US$44.15M−US$191.0Mn/a−10.8×n/a0.1×−468.1%0.0×n/a
EDX Medical Group plc · LSE:EDXUS$43.78MUS$39.96Mn/a92.3×n/a15.4×n/a0.0×n/a
Osang Healthcare Co. Ltd. · KRX:036220US$42.35MUS$24.18Mn/a0.3×n/a0.2×−8.8%0.1×n/a
ABL Diagnostics SA · EURONEXT:ABLDUS$41.27MUS$42.32M38.1×5.5×42.8×5.3×14.2%0.3×n/a
hVIVO plc · LSE:HVOUS$41.02MUS$42.24Mn/a0.7×7.5×1.0×−12.8%0.4×n/a
Harvard Bioscience, Inc. · NASDAQ:HBIOUS$39.60MUS$71.90Mn/a0.8×28.4×7.8×−13.2%7.3×1.34
CytoGen, Inc. · KRX:217330US$38.58MUS$31.66Mn/a1.6×n/a1.6×−38.5%0.4×n/a
Median of the othersUS$43.06MUS$38.80M38.1×2.2×28.4×2.1×−37.5%0.3×1.34

Forecasts

Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
9.50 EUR · Analysts' mean
EPS, year to Dec 2026
0.78 · 1 analyst
Revenue, year to Dec 2026
80.84M · 1 analyst

Team and board

Officers

OfficerRole
Manuel RamosPresidente & CEO
Manuel Ramos OrtegaChairman of the Board of Directors, CEO
Miquel PujolriuCFO
Miquel Pujolriu GiménezSecretary not a member of the Board of Directors
Antonio OrtizCommercial Director of the Animal Division
Dragoljub MilinkovicManaging Director of Zavod
Ivana NovoaHR Director
Javier SehabiagaOperations Director, Human Division
José Manuel GarcíaCommercial Director, Human Division
Mª Jesús CrespoDirector of R&D and Regulatory Affairs, Animal Division
Ramón ClaveraOperations Director, Animal Division
Sandra VillagrasaGeneral Director of Labiana Health
Sergio JiménezDirector of Engineering, Maintenance, and EHS, Human Division
Suva KayaManaging Director of Zoleant
Tania UbachCommercial Director CMO, Animal Division
Xavier Pérez RamosManaging Director of the Animal Division

Board

DirectorRole
Manuel Ramos OrtegaChairman of the Board of Directors, CEO
Carmen Hortalà VallvéVocal
John William NellisMember of the Appointments and Remuneration Committee
Juan Manuel Gil de Escobar DelgadoMember of the Appointments and Remuneration Committee
Juan Ortiz HernándezVocal
Sandra Villagrasa ClementeVocal
Wolfgang Johannes StorfChairman of the Appointments and Remuneration Committee

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck66 slidesOctober 2026
Investor Presentation (October 2022)Investor deck68 slidesOct 25, 2022
H1 2022 Earnings PresentationEarnings27 slidesOctober 2022

Open Decks

Financials

Annual, in EUR

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue75.2M66.3M58.5M57.8M57.0M57.8M
Cost of revenue29.2M25.3M24.1M25.4M21.6M23.8M
Gross profit46.0M40.9M34.3M32.5M35.4M34.1M
Selling, general and administrative22.7M18.2M17.9M
Operating income7.30M5.10M-1.84M-6.23M539.9K2.46M
Depreciation and amortization3.79M4.25M5.09M4.84M5.00M
EBITDA11.1M9.35M3.24M-1.39M5.54M
Interest expense5.91M4.84M3.29M2.11M2.13M
Income before tax1.20M-30.0K-5.27M-7.84M-2.12M541.2K
Net income2.57M253.4K-4.42M-8.94M-1.78M1.07M
Earnings per share, basic0.360.04-0.61-1.25-0.25

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents5.91M6.74M2.96M2.52M3.28M
Short-term investments1.80K80013.9K23.4K11.4K
Receivables10.4M9.42M11.8M8.78M7.93M
Inventory12.0M9.98M11.1M13.8M14.9M
Current assets31.5M28.7M29.0M28.8M29.4M
Property, plant and equipment20.6M
Goodwill-0-0-001.28M
Total assets57.5M52.0M59.1M60.8M68.4M
Accounts payable11.4M8.77M8.76M11.3M8.58M
Current liabilities22.7M22.2M24.7M35.1M30.5M
Long-term debt29.8M26.9M29.7M12.8M23.5M
Total liabilities52.8M49.4M55.7M53.0M56.8M
Shareholders' equity5.08M2.87M3.58M7.74M11.6M
Shares outstanding7.17M7.22M7.22M7.16M7.22M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations1.70M7.19M-1.83M4.68M3.91M
Capital spending-4.44M-3.05M-2.85M-5.45M-4.77M
Free cash flow-2.74M4.15M-4.68M-774.4K-858.7K
Cash from investing-2.95M
Cash from financing-2.50M
Share buybacks-158.9K-158.6K4.17M-1.13M
Change in cash-823.5K3.78M438.6K-762.3K1.74M

Open Financials

Cap table

Built by 6ix from Labiana Health SA’s releases

Common shares
8,489,255
Fully diluted
8,489,255

Fully diluted

LineShares
Common shares8,489,255

Share count over time

CountShares
Nov 22, 20268,489,255

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Antonio OrtizCommercial Director of the Animal Division · Since at least Nov 5, 2026
Dragoljub MilinkovicManaging Director of Zavod · Since at least Nov 5, 2026
Ivana NovoaHR Director · Since at least Nov 5, 2026
Javier SehabiagaOperations Director, Human Division · Since at least Nov 5, 2026
José Manuel GarcíaCommercial Director, Human Division · Since at least Nov 5, 2026
Mª Jesús CrespoDirector of R&D and Regulatory Affairs, Animal Division · Since at least Nov 5, 2026
Manuel RamosPresidente & CEO · Since at least Nov 5, 2026
Miquel PujolriuCFO · Since at least Nov 5, 2026
Ramón ClaveraOperations Director, Animal Division · Since at least Nov 5, 2026
Sandra VillagrasaGeneral Director of Labiana Health · Since at least Nov 5, 2026
All 14 people
PersonSeat
Sergio JiménezDirector of Engineering, Maintenance, and EHS, Human Division · Since at least Nov 5, 2026
Suva KayaManaging Director of Zoleant · Since at least Nov 5, 2026
Tania UbachCommercial Director CMO, Animal Division · Since at least Nov 5, 2026
Xavier Pérez RamosManaging Director of the Animal Division · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Labiana Health SA.